An early stage startup providing healthcare solutions that enable personalized management of obesity and other chronic diseases.
Employees: 11-50
Phone: +1 877-673-0981
Total raised: $8.8M
Founded date: 2017
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.05.2024 | - | $7.8M | - |
| 29.11.2018 | Seed | $1M | - |
Mentions in press and media 11
| Date | Title | Description |
| 17.05.2024 | Revolutionizing Obesity Treatment with Precision Medicine | Phenomix Sciences, a cutting-edge biotechnology company, has secured a whopping $7.8 million in funding to accelerate the adoption of precision medicine in the treatment of obesity. This influx of capital, including $5.5 million in Series A... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M in Funding | Phenomix Sciences, a Menlo Park, Calif.-based precision medicine biotechnology company that brings data intelligence to the treatment of obesity, raised $7.8m in funding. The round included $5.5m in Series A funding from new investors DexCo... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption | What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and La... |
| 04.04.2024 | Phenomix Sciences Launches 3-in-1 Obesity Phenotyping Test | What You Should Know: – Phenomix Sciences, a leader in precision medicine for obesity, launches a new MyPhenome test that identifies all three key obesity phenotypes in a single test. – The new test identifies all three of the company’s sig... |
| 30.03.2023 | Phenomix Sciences Launches Saliva Test to Predict Obesity Phenotype | What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungr... |
| 27.05.2022 | Phenomix Sciences Launches Obesity Biobanking Registry Studying Personalized Treatment Options Based on Genetics | What You Should Know: – Biotech company Phenomix Sciences launches its biobanking registry, marking the first obesity registry to study the impact of personalized treatment based on phenotyping. The impact of this biobanking registry and th... |
| 21.04.2021 | Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices | What You Should Know: – Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patie... |
| 15.10.2019 | Abilitech Medical Wins the 2019 Minnesota Cup | Medical device company Abilitech Medical won the Minnesota Cup's Grand Prize on Monday night, securing $50,000 to grow its business. Abilitech landed an additional $25,000 as the competition's top women-led startup. Prior to Monday night's ... |
| 29.11.2018 | Phenomix Sciences, an early-stage Mayo Clinic startup, launches with $1 million in seed fund to fight obesity | Phenomix Sciences, an early-stage spinout of the Mayo Clinic startup company focused on personalized treatments for chronic diseases, has secured $1 million in seed round of financing to enable commercialization of a new clinical test for o... |
| 08.03.2007 | Phenomix Raises $55M Series C | San Diego-based Phenomix, a company developing therapeutics for the treatment of type 2 diabetes, hepatitis C, and other diseases, said today that it has closed on $55M in a Series C funding. The funding was led by Nomura Phase4 Ventures, a... |
Show more